Search results
Results from the WOW.Com Content Network
Microsoft Intune (formerly Microsoft Endpoint Manager and Windows Intune) is a Microsoft cloud-based unified endpoint management service for both corporate and BYOD devices. [2] It extends some of the "on-premises" functionality of Microsoft Configuration Manager to the Microsoft Azure cloud.
Microsoft family features (includes family safety features formerly known as Microsoft Family Safety, formerly Parental Controls in Windows 7 and Vista) is a free set of features available on Windows 10 PC and Mobile that is bundled with the Windows 10, Home edition operating system.
A regional lockout (or region coding) is a class of digital rights management preventing the use of a certain product or service, such as multimedia or a hardware device, outside a certain region or territory.
Mobile device management (MDM) is the administration of mobile devices, such as smartphones, tablet computers, and laptops.MDM is usually implemented with the use of a third-party product that has management features for particular vendors of mobile devices.
Ad blockers insert code into your browser to block ads, which can negatively impact website performance, break functionality, and even hide messages in AOL Mail. We recommend unblocking AOL Mail websites to avoid facing these issues. Doing this will also unblock ads. Adjust Other settings
Unix-like operating systems commonly implement IP address blocking using a TCP wrapper, configured by host access control files /etc/hosts.deny and /etc/hosts.allow.. Both companies and schools offering remote user access use Linux programs such as DenyHosts or Fail2ban for protection from unauthorized access while allowing permitted remote access.
The enterprise edition of Windows 10 offers additional security features; administrators can set up policies for the automatic encryption of sensitive data, selectively block applications from accessing encrypted data, and enable Device Guard—a system which allows administrators to enforce a high-security environment by blocking the ...
(Reuters) -Regeneron Pharmaceuticals said on Monday the U.S. FDA has declined approval for its blood cancer therapy for two forms of lymphoma on concerns over the progress of ongoing confirmatory ...